The quality and credibility of medic al publications vary substantially. The greatest problem associated with publishing information that is not entirely valid is that it may mislead physicians in their clinical management of patients. This is true particularly because some published literature looks quite believable at first reading, even though it does not stand up to closer scrutiny. Recently, emphasis on evidence-based medicine (EBM) has sought to address this problem.
Movement toward EBM does not necessarily mean that every article published must be the result of a double-bl ind, placebo-controlled trial. This is fortunate for publishers, because if that were the case , we would have far fewer journals. Nevertheless, the growing awareness of the importance of EBM emphasizes the need for critical analysis and scrutiny of every article we read . It also provides a structure to help evaluate the credibility of a publication. Hence, it is valuable for all otolaryngologists to acquire a basic understanding ofEBM.
In order to approach a problem using the EBM paradigm, the information sought on a typical topic is structured into questions that can be answered . These questions should be addressed efficiently, using the best possible evidence (see information below on levels of evidence) to elucidate the answers. The evidence obtained is evaluated critically to determine its validity and to determine whether it answers the questions in a useful way. The results are then combined with information based upon clinical expertise and previous experience gleaned from the literature. Then, outcomes are evaluated. This systematic approach to expanding scientific know ledge is the essence of the EBM " movement," although a great deal of attention is paid to one portion of this paradigm, spec ifically: the level of evidence (LOE).
The LOE helps a reader understand the credibility of the results presented. Are they valid? That is, are they unbiased and true? Validity does not necessarily predict clinical relevance, but it is certainly important to understand whether reported information is believable before deciding whether to rely upon it for changes in clinical management.
Evidence may be classified into five categories. Level 1 evidence (the highest category) includes randomized, contro lled tria ls; meta-analyses ; systematic reviews ; and reports of diagnostic sensitivity and specificity. In randomized, controlled tria ls, two identical groups are divided randomly into a control group and an experimental group; both groups are followed prospectively for specific endpoints. Meta -analyses involve quantitative synthesis (or pooling) ofdata from numerous independent clinical trials . Systematic reviews utilize specific methods to identify primary studies, assess their quality, and rev iew their data . Diagnostic sensitivity and specificity studies report the true positive and negative rates for diagnostic tests .
Cohort studies are classified as level 2 evidence. They involve groups of peop le who are identified because of their exposure to a particu lar agent , for example, and who are followed for selected outcomes. Case control studies (level 3 evidence) The old adage "Save me from the doctor who has just read a paper" calls to mind the pitfa lls associated with lessthan -critical absorption of information from the medical literatu re. Evaluating each paper for LOE helps physicians sort out articles on which they should rely from those with insuffic ient power to support a clinical decision .
In addition to using LOE to evaluate published literature, otolaryngo logists shou ld also remember class ification of evide nce when designing a study or preparing to write a pape r. Often , it takes surprisingly little extra effort to increase the credibi lity ofa study by modifying the design to increase its evidence level. This can sometimes make the difference between valid and invalid results, and between acceptance and rejection of a manuscript.
Medical writers and pub lishers are still struggling with sensib le adoption of the principles of EBM. Overall, the trend toward a more rigorous study design appears healthy, and heightened awareness ofthe strengths and weaknesses of the study design of each published paper is certainly adva ntageous to physicians and our patients.
